The elevation of RAD51-AS1 was uncovered to repress cell invasion, glycolysis process, and migration by mediating NDRG2 expression via sequestering miR-29b/c-3p, leading to the reduction of colorectal cancer progression (Li et al. 2021a, b). Here, RAD51 is linked to colorectal cancer.